Literature DB >> 15824255

Early differential diagnosis of multiple sclerosis using a new oligoclonal band test.

Luisa M Villar1, Jaime Masjuan, María C Sádaba, Pedro González-Porqué, José Plaza, Alfredo Bootello, José C Alvarez-Cermeño.   

Abstract

BACKGROUND: Intrathecal IgG synthesis (ITGS), in conjunction with magnetic resonance imaging, can help in the early diagnosis of multiple sclerosis (MS). Recently, we developed a new oligoclonal IgG band (OCGB) test for ITGS detection that is more sensitive and easier to interpret than previously described methods.
OBJECTIVE: To assess the accuracy of a new OCGB detection test in the diagnosis of MS.
DESIGN: Prospective observational study.
SETTING: A hospital neurology department. Patients A total of 385 patients with various neurologic disorders. MAIN OUTCOME MEASURES: The sensitivity and specificity of the OCGB detection test for MS diagnosis.
RESULTS: Intrathecal IgG synthesis was found in 127 patients with MS (96.2%), 18 (35.3%) with central nervous system infections, and 1 with motor neuron disease. Two patterns reflected ITGS. One pattern, showing OCGBs restricted to cerebrospinal fluid, was predominantly found in MS. The other pattern, with OCGBs in serum and additional bands in cerebrospinal fluid, was mostly found in central nervous system infections. No patients with other inflammatory neurologic diseases showed ITGS. These patients frequently displayed a mirror pattern, with identical bands in serum and cerebrospinal fluid. Considering all patients, the sensitivity for the diagnosis of MS was 96.2%, and the specificity was 92.5%. Excluding infections, which usually do not present a differential diagnosis problem with MS, the sensitivity was still 96.2%, and the specificity increased to 99.5%.
CONCLUSION: The accuracy of this OCGB method reinforces the value of cerebrospinal fluid studies in the early differential diagnosis of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824255     DOI: 10.1001/archneur.62.4.574

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  16 in total

1.  Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.

Authors:  Stefan Presslauer; Dejan Milosavljevic; Thomas Brücke; Peter Bayer; Wolfgang Hübl; Walter Hübl
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

2.  MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.

Authors:  Hagen B Huttner; Peter D Schellinger; Tobias Struffert; Gregor Richter; Tobias Engelhorn; Teresa Bassemir; Mathias Mäurer; Meritxell Garcia; Stefan Schwab; Martin Köhrmann; Arnd Doerfler
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Authors:  N Marín; H Eixarch; M J Mansilla; E Rodríguez-Martín; M Mecha; C Guaza; J C Álvarez-Cermeño; X Montalban; L M Villar; C Espejo
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis.

Authors:  Ursula Muñoz; Cristina Sebal; Esther Escudero; Margaret Esiri; John Tzartos; Carolyn Sloan; Mari Cruz Sadaba
Journal:  Cell Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.046

5.  Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.

Authors:  Stefan Presslauer; Dejan Milosavljevic; Wolfgang Huebl; Silvia Parigger; Gabriele Schneider-Koch; Thomas Bruecke
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 6.  Disease Modifying Therapy in Multiple Sclerosis.

Authors:  U E Williams; S K Oparah; E E Philip-Ephraim
Journal:  Int Sch Res Notices       Date:  2014-07-07

7.  CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.

Authors:  Ahmed Abdelhak; Tilman Hottenrott; Christoph Mayer; Gudrun Hintereder; Uwe K Zettl; Oliver Stich; Hayrettin Tumani
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 8.  The Role of B Cells in Primary Progressive Multiple Sclerosis.

Authors:  Jameson P Holloman; Robert C Axtell; Nancy L Monson; Gregory F Wu
Journal:  Front Neurol       Date:  2021-06-07       Impact factor: 4.086

9.  Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger.

Authors:  Edward L Hogan; Maria Podbielska; Joan O'Keeffe
Journal:  J Clin Cell Immunol       Date:  2013-06

10.  Comparison of neurophysiological and MRI findings of patients with multiple sclerosis using oligoclonal band technique.

Authors:  Hamit Y Ellidag; Esin Eren; Nezahat Erdogan; Sabiha Ture; Necat Yilmaz
Journal:  Ann Neurosci       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.